Preliminary data suggest that α-syn RT-QuIC may have a higher diagnostic performance in DLB patients with diffuse neocortical pathology, and who are carriers of GBA mutations or the APOE ε4 allele (Jin et al., 2022). This evidence concerns the gene APOE and Lewy body dementia.